Australia markets open in 7 hours 47 minutes

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
85.08-0.03 (-0.03%)
As of 11:11AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close85.10
Open85.72
Bid84.82 x 900
Ask84.96 x 800
Day's range82.42 - 85.94
52-week range30.05 - 189.89
Volume74,641
Avg. volume574,364
Market cap2.512B
Beta (5Y monthly)1.49
PE ratio (TTM)4.84
EPS (TTM)17.59
Earnings date08 Nov 2021 - 12 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est141.00
  • Motley Fool

    Is Moderna a Good Healthcare Stock to Buy Now?

    Moderna's (NASDAQ: MRNA) COVID-19 vaccine has created a multibillion-dollar revenue stream for the company, but is the massive $130 billion valuation of the business justified? In this Fool Live video clip, recorded on Oct. 4, Fool.com contributors Rachel Warren and Jason Hall discuss whether Moderna could be a smart buy despite its nosebleed-level valuation. Rachel Warren: It's funny, because I write about healthcare stocks a lot and I'm a healthcare writer here at the Fool.

  • Motley Fool

    3 Top Healthcare Stocks to Buy Right Now

    After all, Wall Street doesn't sell a stock unless it believes there is a better place for the money -- at least in the short term. Knowing you plan to hold for years, and not having anyone but yourself to answer to, can focus your analysis on the company and its prospects. As company reputations go, Johnson & Johnson offers one of the strangest juxtapositions.

  • Motley Fool

    What's Going on With Fulgent Genetics?

    The company is leveraging success with its COVID-19 tests to position itself better for a post-pandemic world.